Hepatic resection in adolescent and young adult patients with hepatocellular carcinoma

doi:10.5306/wjco.v17.i5.117168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

(20)

(27)

(0)

(45)

(405)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Oncol. May 24, 2026; 17(5): 117168
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.117168

Table 1 Clinicopathological characteristics of the study participants

Clinical features	Data
Age (year)	69.6
Sex (male/female)	684/201
BMI (kg/m²)	26.8
HBV	120 (13.6)
HCV	367 (41.5)
LC	341 (38.5)
AFP (ng/mL)	4273
PIVKA-II (mAU/mL)	6482
Child-Pugh class (A/B/C/NA)	752/96/0/37
Partial hepatectomy	367 (41.5)
Laparoscopic hepatectomy	304 (34.4)
Vascular invasion (+)	269 (30.4)
Single tumor	640 (72.3)
Tumor diameter (mm)	42.4
pStage (I/II/III/IV/NA)	143/337/243/100/62
Operative time (min)	313
Intraoperative blood loss (mL)	745
Positive surgical margin	82 (9.27)
Blood transfusion	112 (12.7)
Postoperative hospital stays (days)	15.7
Morbidity	106

Data are presented as n (%), n, or mean, unless otherwise indicated. AFP: Alpha-fetoprotein; BMI: Body mass index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; LC: Liver cirrhosis; NA: Not available; PIVKA-II: Protein induced by vitamin K absence or antagonist-II; pStage: Pathological stage defined according to the Union for International Cancer Control (8^th edition).

Full Size Table

Citation: Ueda J, Taniai N, Yoshioka M, Matsushita A, Mizutani S, Kawano Y, Shimizu T, Kanda T, Murokawa T, Takata H, Furuki H, Aoki Y, Kawashima M, Irie T, Ono T, Haruna T, Yoshimori D, Endo K, Hamaguchi A, Yoshida H. Hepatic resection in adolescent and young adult patients with hepatocellular carcinoma. World J Clin Oncol 2026; 17(5): 117168
URL: https://www.wjgnet.com/2218-4333/full/v17/i5/117168.htm
DOI: https://dx.doi.org/10.5306/wjco.v17.i5.117168

Ueda J, Taniai N, Yoshioka M, Matsushita A, Mizutani S, Kawano Y, Shimizu T, Kanda T, Murokawa T, Takata H, Furuki H, Aoki Y, Kawashima M, Irie T, Ono T, Haruna T, Yoshimori D, Endo K, Hamaguchi A, Yoshida H. Hepatic resection in adolescent and young adult patients with hepatocellular carcinoma. World J Clin Oncol 2026; 17(5): 117168 [DOI: 10.5306/wjco.v17.i5.117168]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.